Does it make sense to develop new centrally acting cardiovascular drugs?

Clinical and Experimental Pharmacology & Physiology
P BousquetJ Feldman

Abstract

1. The autonomic nervous system plays a pivotal role in modulating all the components of the cardiovascular regulation. Therefore, one can assume that drugs targeting this system may be useful in the management of several cardiovascular diseases. 2. Drugs acting on central nervous system centres seem to be modulators rather than blockers; as such, they are expected to preserve the contraregulatory processes and to generate only a few side effects. 3. Because the sympathetic nervous system is largely involved in the regulation of vasomotor tone, centrally acting antihypertensive drugs were developed first. 4. Recently, new leader compounds selective for non- adrenergic imidazoline recepetors have been synthetized. Although such drugs have no capacity to activate alpha2-adrenoceptors, they have been proven to be hypotensive. These drugs are expected to be even better tolerated than the currently available centrally active drugs. They may also have additional beneficial effects. 5. Here, the experimental evidence suggesting that such drugs may be useful in the management of some cardiac arrhythmias and/or left ventricular dysfunction will be reviewed.

References

Nov 1, 1992·Clinical Pharmacology and Therapeutics·J P McKaigue, D W Harron
Jul 23, 1992·The New England Journal of Medicine·UNKNOWN Cardiac Arrhythmia Suppression Trial II Investigators
Aug 10, 1989·The New England Journal of Medicine·UNKNOWN Cardiac Arrhythmia Suppression Trial (CAST) Investigators
Sep 27, 1984·The New England Journal of Medicine·J N CohnT Rector
Mar 1, 1983·The American Journal of Cardiology·J B HermillerC V Leier
Jan 29, 1981·European Journal of Pharmacology·P BousquetJ Schwartz
Dec 1, 1981·Clinical Pharmacology and Therapeutics·T D GilesR L Dillenkoffer
Nov 1, 1996·Naunyn-Schmiedeberg's Archives of Pharmacology·J C RoegelP Bousquet
Apr 29, 1998·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·C M White
Jul 23, 1999·Annals of the New York Academy of Sciences·V BrubanP Bousquet
Aug 2, 2000·American Journal of Hypertension·R D Brook, S Julius
Sep 12, 2000·Current Hypertension Reports·P Palatini, S Julius

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.